Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro

Guang-Dong Pan; Jian-Qing Yang; Lv-Nan Yan; Guang-Ping Chu; Qiang Liu; Yi Xiao; Lin Yuan
January 2009
World Journal of Gastroenterology;1/28/2009, Vol. 15 Issue 4, p431
Academic Journal
AIM: To explore the possibility of reversing multi-drug resistance (MDR) to HepG2/mdr1 in vitro and in vivo with RNA interference (RNAi). METHODS: HepG2/mdr1 was obtained by cloning the whole gene mdr1 into HepG2 cells. shRNA targeting sequence was designed to be homologous to the P-gp encoding MDR1 mRNA consensus sequence. pSUPERshRNA/ mdr1 was constructed using the enzymedigested technique. HepG2/mdr1 cells were transfected with vectors of pSUPER-shRNA/mdr1 to measure their efficacy by real-time PCR for mdr1 mRNA, flow cytometry (FCM) for P-gp expression, and Rhodamine efflux, MTT method for HepG2/mdr1 function, respectively. In vivo, mice tumors were treated by injecting pSUPER-shRNA/mdr1 in situ and into intraabdominal cavity. Tumors were collected to create cell suspension and cryosections after chemothearpy with adiramycin and mytomycin. The cell suspension was incubated in RPMI-1640 supplemented with G418 to screen stable cells for appreciating the reversal of MDR. Cryosections were treated with immunohistochemistry technique to show the effectiveness of transfection and the expression of P-gp. RESULTS: pSUPER-shRNA/mdr1 was successfully constructed, which was confirmed by sequencing. The MDR phenotype of HepG2/mdr1 was decreased significantly in vitro transfection. HepG2/mdr1 showing its MDR was reversed notably in P-gp expression (11.0% vs 98.2%, P < 0.01). Real-time PCR showed that mRNA/mdr1 was lower in test groups than in control groups (18.73 ± 1.33 vs 68.03 ± 2.21, P < 0.001). Compared with HepG2, the sensitivity of HepG2/ mdr1 and HepG2/mdr1-dsRNA cells to ADM was decreased by 1.64 times and 15.6 times, respectively. The accumulation of DNR in positive groups was decreased evidently. In vivo, the p-gp expression in positive groups was significantly lower than that in control groups (65.1% vs 94.1%, P < 0.05). The tumor suppressing rate in test groups was 57.8%. After chemotherapy, the growth rate in test groups was lower than that in control groups (700.14 ± 35.61 vs 1659.70 ± 152.54, P < 0.05). Similar results were also observed under fluorescence microscope, and confirmed by Image-Pro Plus 4.5 analysis. CONCLUSION: pSUPER-shRNA/mdr1 vector system allows simple, stable and durable nonviral knockdown of P-gp by RNAi in malignant cells and animals to restore their sensitivity to adriamycin.


Related Articles

  • Downregulating immunogenicity of Schwann cells via inhibiting a potential target of class II transactivator (CIITA) gene. Yi Yang; Wenda Dai; Zhengrong Chen; Zuoqin Yan; Zhenjun Yao; Chi Zhang // BioScience Trends;Feb2013, Vol. 7 Issue 1, p50 

    Immunological rejection induced by allogeneic Schwann cells remains a problem for construction of artificial nerves. Class II transactivator (CIITA) gene is a chief regulator of major histocompatibility complex class II (MHC II) molecules which contributes to the immunogenicity of Schwann cells....

  • Real-time PCR: Advancing RNA Interference and MicroRNA Studies. Chen, Caifu; McDonald, Kelly; Wong, Ada H.; Petrauskene, Olga V.; Furtado, Manohar R. // Pharmaceutical Discovery;May2005 Supplement, Vol. 5, p31 

    In recent years, researchers have made great strides toward understanding the role of endogenous small RNAs (miRNAs) in gene regulation and harnessing the power of exogenous small RNAs (siRNAs and shRNAs) as laboratory tools to manipulate messenger RNA (mRNA) levels. As the field has evolved,...

  • MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Sun, Kai; Wang, Wei; Zeng, Jun-jie; Wu, Cheng-tang; Lei, Shang-tong; Li, Guo-xin // Acta Pharmacologica Sinica;Mar2011, Vol. 32 Issue 3, p375 

    Aim:To investigate the regulatory effect of microRNA-221 (miR-221) on CDKN1C/p57 expression in colorectal carcinoma (CRC).Methods:Thirty four CRC and adjacent non-tumorous tissue samples were collected individually. Total RNA and protein were isolatedand from these samples and four human...

  • Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3. Shi, HuiRong; Liu, HuiNa; Zhao, GuoQiang // Molecular Biology Reports;Oct2012, Vol. 39 Issue 10, p9299 

    RNA interference is an evolutionarily conserved cellular defense mechanism that protects cells from hostile genes and regulates the function of normal genes during growth and development. In this study, we established GFP-siFAK-DLC1 vector and transfect the vector into OVCAR-3 cells. RT-PCR and...

  • Inhibition of C35 gene expression by small interfering RNA induces apoptosis of breast cancer cells. Qiaoqiao Liu; Kun Yin; Song Zhu; Ling Zhang; Peie Wen; Cuiling Li; Dianbo Zhang; Miao Liu; Ge Yan // BioScience Trends;Oct2010, Vol. 4 Issue 5, p254 

    C35 was reported to be a new biomarker and therapeutic target for breast cancer. To explore the functional importance of C35, we constructed small interfering RNA (siRNA) targeting C35 and investigated the effects of the siRNAs on C35 expression and apoptosis of T47D cells. C35 siRNAs were...

  • Effect of siRNA-Livin on drug resistance to chemotherapy in glioma U251 cells and CD133+ stem cells. YANG LIU; QIANG GUO; HAO ZHANG; GEN-HUA LI; SONG FENG; XI-ZHENYU; LING-SHENG KONG; LEI ZHAO; FENG JIN // Experimental & Therapeutic Medicine;Oct2015, Vol. 10 Issue 4, p1317 

    The aim of the present study was to observe the effect of siRNA-Livin on the expression of multidrug resistance-associated protein (MRP) genes in a U251 cell line and U251 stem cells. CD133+ cancer stem cells were identified and isolated from the U251 glioblastoma cells, and morphological...

  • p16INK4A Positively Regulates Cyclin D1 and E2F1 through Negative Control of AUF1. Al-Khalaf, Huda H.; Colak, Dilek; Al-Saif, Maher; Al-Bakheet, Albandary; Hendrayani, Siti-Faujiah; Al-Yousef, Nujoud; Kaya, Namik; Khabar, Khalid S.; Aboussekhra, Abdelilah // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: The cyclin-D/CDK4,6/p16INK4a/pRB/E2F pathway, a key regulator of the critical G1 to S phase transition of the cell cycle, is universally disrupted in human cancer. However, the precise function of the different members of this pathway and their functional interplay are still not well...

  • Ubiquitin-Conjugating Enzyme 9 Promotes Epithelial Ovarian Cancer Cell Proliferation in Vitro. Mei Dong; Xiaoyan Pang; Yang Xu; Fang Wen; Yi Zhang // International Journal of Molecular Sciences;Jun2013, Vol. 14 Issue 6, p11061 

    Epithelial ovarian cancer (EOC) is one of the leading causes of cancer deaths in women worldwide. Ubiquitin-conjugating enzyme 9 (Ubc9), the sole conjugating enzyme for sumoylation, regulates protein function and plays an important role in sumoylation-mediated cellular pathways. Although...

  • Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib. Chen, Chen; Shen, Hui; Yang, Jing; Chen, Qiao; Xu, Wen // Journal of Cancer Research & Clinical Oncology;Jan2011, Vol. 137 Issue 1, p9 

    Purpose: To investigate the preventive effect of celecoxib, a specific cyclooxygenase-2 (Cox-2) inhibitor, on the development of chemoresistance in breast cancer cell line, MCF-7, and explore the mechanism of the action. Methods: Chemoresistance phenotype was established by treating MCF-7 cells...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics